ACTIVE SUBSTANCE / INN

TAZAROTENE

Brand name(s): ARAZLO, DUOBRII, AVAGE, HALOBETASOL PROPIONATE AND TAZAROTENE, TAZORAC, FABIOR, TAZAROTENE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA021184
NDA202428
ACTIVE SUBSTANCE
Tazarotene
REGULATORS
FDA
SPONSORS / MAH
FOUGERA PHARMS INC, ALMIRALL, BAUSCH
TOTAL APPLICATIONS
8
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TAZORACNDA021184ALMIRALLPrescription
AVAGENDA021184ALMIRALLPrescription
TAZAROTENEANDA208662COSETTEPrescription
TAZAROTENEANDA211175FOUGERA PHARMS INCDiscontinued
HALOBETASOL PROPIONATE AND TAZAROTENEANDA217190SUN PHARMA CANADAPrescription
FABIORNDA202428MAYNE PHARMAPrescription
DUOBRIINDA209354BAUSCHPrescription
ARAZLONDA211882BAUSCHPrescription

FULL INTELLIGENCE ON TAZAROTENE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →